New Developments in Bipolar Spectrum Disorders in Children and Adolescents

New Developments in Bipolar Spectrum Disorders in Children and Adolescents

On-Demand Webcast
FACULTY

Melissa DelBello, MD, MS (Chairperson)
Dr. Stanley and Mickey Kaplan Professor and
Chair of Psychiatry & Behavioral Neuroscience
University of Cincinnati College of Medicine
Cincinnati, OH

Kiki Chang, MD 
Professor of Psychiatry and Behavioral Sciences
Division of Child Psychiatry
Director, Pediatric Bipolar Disorders Clinic
Stanford University School of Medicine
Palo Alto, CA

Adelaide Robb, MD 
Professor of Psychiatry and Pediatrics
The George Washington University
Division Chief, Psychology and Behavioral Health
Children’s National Health System
Washington, DC

For full faculty bios, please call 609-371-1137.

INTENDED LEARNERS

This activity is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.

LEARNING OBJECTIVES

After completing this activity, participants should be able to:

  • Differentiate bipolar depression from other disorders in children and adolescents
  • Recognize and manage comorbid illnesses in children and adolescents with bipolar disorder
  • Apply evidence-based practices in the pharmacologic treatment of bipolar depression in children and adolescents
ACTIVITY OVERVIEW

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: 12/22/2017
Expiration Date: 12/22/2018
Estimated time to complete: 1.5 hours

For questions regarding this educational activity, please call 609-371-1137.

ACCREDITATION INFORMATION

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and CMEology. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.5 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.5 contact hours.

CE INFORMATION: APA

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content.

Instructional Level: Advanced

PLANNING COMMITTEE

The planning committee comprises Kiki Chang, MD, Melissa DelBello, MD, MS, Douglas L. Noordsy, MD, Andrew Penn, RN, MS, NP, CNS, APRN-BC, and Adelaide Robb, MD; Rob Lowney, Dannielle McGuire, and Dana Ravyn, PhD, MPH, CMEology; and Raquel Gaerlan, Mary Johnson, Mike Kearney, Meaghan Benci, Randy Robbin, and John Savage, NACCME.

Independent Clinical Reviewer: Douglas L. Noordsy, MD, Clinical Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine; Director of Sports Psychiatry, Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California

Nurse Planner: Andrew Penn, RN, MS, NP, CNS, APRN-BC, Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CA

FINANCIAL DISCLOSURE AND CONFLICTS OF INTEREST

 

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. 

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and level of evidence. 

Dr. Chang: Consultant for Sunovion Pharmaceuticals Inc. and Octapharma USA Inc. 

Dr. DelBello: Consultant/Advisor for Akili, Johnson & Johnson, Lundbeck, Neuronetics, Pfizer Inc., Sunovion Pharmaceuticals Inc., Supernus, and Takeda Pharmaceuticals; Research/Grant Support from Amarex, Johnson & Johnson, Lundbeck, Otsuka, Pfizer Inc., Shire, Sunovion Pharmaceuticals Inc., and Supernus. 

Dr. Robb: Consultant/Advisor for Actavis/Allergan/Forest, Aevi Genomic Medicine/Medgenics (DSMB), Bracket, Guilford Press, Lundbeck/Takeda, Neuronetics (DSMB), NICHD EKS, NIMH (DSMB), Sunovion Pharmaceuticals Inc., and University of Cambridge; Research/Grant Support from Actavis/Allergan/Forest, Lundbeck/ Takeda, National Center for Advancing Translational Sciences, NINDS, Pfizer, Inc., Supernus, and SyneuRx; Shareholder in Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Inc. and Pfizer, Inc.; Other Income: Honoraria for Participation in Another Meeting: American Academy of Child and Adolescent Psychiatry and CAPSGW Local Branch, American Academy of Pediatrics, Case Western Reserve University, College of Psychiatric & Neurologic Pharmacists, Neuroscience Education Institute, Nevada Psychiatric Association, and North American Center for CME; Travel support for participation in meetings from Actavis/Allergan/Forest, American Academy of Child and Adolescent Psychiatry American Academy of Pediatrics, Case Western Reserve University, College of Psychiatric & Neurologic Pharmacists, Lundbeck/Takeda, Neuroscience Education Institute, Nevada Psychiatric Association, North American Center for CME, Pfizer, Inc., Sunovion Pharmaceuticals Inc., and Supernus. 

Mr. Penn and Dr. Noordsy disclosed no relevant financial relationships with any commercial interests. 

Ms. Gaerlan, Mrs. Johnson, Mr. Kearney, Mrs. Benci, Mr. Robbin, Mr. Savage, Mr. Lowney, Ms. McGuire, and Dr. Ravyn disclosed no relevant financial relationships with any commercial interests. 

NACCME requires faculty to inform participants whenever off-label/ unapproved uses of drugs and/or devices are discussed in their presentations. 

Off-label/unapproved uses of drugs and/or devices will be disclosed prior to the start of the symposium.

HARDWARE/SOFTWARE REQUIREMENTS

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC (NACCME). All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from NACCME. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

This activity is jointly provided by North American Center for Continuing Medical Education, LLC, an HMP Communications Holdings Company, and CMEology.

GRANT SUPPORT

This activity is supported by an educational grant from Sunovion Pharmaceuticals, Inc.